NeueHealth
NEUE
NEUE was delisted on the 1st of October, 2025.
41 hedge funds and large institutions have $28.2M invested in NeueHealth in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
8% more funds holding
Funds holding: 38 → 41 (+3)
1.96% less ownership
Funds ownership: 64.9% → 62.94% (-2%)
16% less capital invested
Capital invested by funds: $33.7M → $28.2M (-$5.48M)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pathway Capital Management
Irvine,
California
|
+$66.6K |
| 2 |
BlackRock
New York
|
+$35.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.91K |
| 5 |
IC
Innealta Capital
Austin,
Texas
|
+$892 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGH
Partners Group Holding
Baar-Zug,
Switzerland
|
-$81.9K |
| 2 |
Morgan Stanley
New York
|
-$15.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6.25K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$5.47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.32K |
NEUE Hedge Fund Activity: Q2 2024 in Review
41 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in NeueHealth (NEUE) for Q2 2024, worth a combined $28.2M — down 16% from $33.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NEUE positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Pathway Capital Management, opening a new position worth an estimated $66.6K. The largest seller was Partners Group Holding, cutting an estimated $81.9K.
- 41 institutional investors held NeueHealth (NEUE) as of Q2 2024, up from 38 in Q1 2024.
- Funds reported $28.2M of NeueHealth stock for Q2 2024, down 16% quarter-over-quarter.
- 4 funds opened new NeueHealth positions in Q2 2024 and 1 closed out, a net change of +3 holders.
- The largest NeueHealth buyer in Q2 2024 was Pathway Capital Management, an estimated $66.6K added.
- The largest NeueHealth seller in Q2 2024 was Partners Group Holding, an estimated $81.9K sold.
Based on aggregated 13F filings for Q2 2024.